Hervolution Therapeutics
- Business Model
- B2B
- Website
- hervolutiontx.com
- Total Funding
- $18.2M
- Last Round
- $6.5M SeedDec 2024
- Rounds
- 2
About
Treating cancer by targeting tumor viruses within the human genome.
Summary
Hervolution Therapeutics is a Biotech company. It has raised $18.2M in total across 2 rounds, most recently a $6.5M Seed round in Dec 2024. Investors include European Innovation Council Fund and Novo Nordisk Foundation.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...